Search Results 1061-1070 of 18450 for prednisone

  1. Glucosamine: Does it protect cartilage in osteoarthritis? - Mayo Clinic

    Prednisone and other corticosteroids · Reverse total shoulder replacement · Robotic-arm assisted knee resurfacing · Seeing inside the heart with MRI · Shoulder ...

  2. A Study to Test Adding Pembrolizumab to Olaparib Alone as Therapy for Patients with Pancreatic Cancer That Has Spread with Inherited BRCA Mutations - Mayo Clinic

    Patients must not have had a prior diagnosis of immunodeficiency or receiving systemic steroid therapy (defined as ≥ 10 mg prednisone or equivalent) or any ...

  3. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma - Mayo Clinic

    Concomitant high dose corticosteroids (concurrent use of corticosteroids); EXCEPTION: patients may be on chronic steroids (maximum dose 20 mg/day prednisone ...

  4. An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease - Mayo Clinic

    treatment with corticosteroids at a dose that exceeds the prednisone equivalent of > 40 mg;; treatment with immuno-modulatory agents (e.g., AZA, 6-MP, or MTX); ...

  5. A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers - Mayo Clinic

    ... prednisone 10 mg/day). Low-dose physiologic replacement therapy with corticosteroids equivalent to prednisone 10 mg/day or lower is acceptable. Active ...

  6. A Study of ONO-7475 in Patients With Acute Leukemias - Mayo Clinic

    Daily requirement of ≥ 10 mg/day of prednisone or equivalent dose of other corticosteroids. Prior HSCT within 12 weeks of the first dose of study treatment ...

  7. Betamethasone sodium phosphate and betamethasone acetate (injection route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  8. FORTIFI-HN01: A Study Of Ficerafusp Alfa (BCA101) Or Placebo In Combination With Pembrolizumab In First-Line PD-L1-pos, R Or M HNSCC - Mayo Clinic

    * Any condition requiring systemic treatment with either corticosteroids (\>10 mg daily of prednisone or equivalent) or other immunosuppressive medication ...

  9. A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF - Mayo Clinic

    A dose of ≤ 15 mg/day prednisone, or equivalent, is acceptable if unchanged for ≥ 10 weeks before Visit 1a and is expected to remain unchanged during the ...

  10. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma - Mayo Clinic

    ... prednisone equivalent or less). Patients who have received live attenuated vaccines within 30 days of the first dose of trial treatment are eligible at the ...